126 related articles for article (PubMed ID: 2538693)
21. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
[TBL] [Abstract][Full Text] [Related]
22. Benzomorphan binding sites in rat lumbo-sacral spinal cord.
Gouardéres C; Audigier Y; Cros J
Eur J Pharmacol; 1982 Mar; 78(4):483-6. PubMed ID: 6281039
[TBL] [Abstract][Full Text] [Related]
23. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
Nock B; Rajpara A; O'Connor LH; Cicero TJ
Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
[TBL] [Abstract][Full Text] [Related]
24. Modulation of rat brain opioid receptors by cannabinoids.
Vaysse PJ; Gardner EL; Zukin RS
J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
[TBL] [Abstract][Full Text] [Related]
25. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
Nishimura S; Pasternak GW
Brain Res; 1982 Sep; 248(1):192-5. PubMed ID: 6289993
[TBL] [Abstract][Full Text] [Related]
26. Endogenous ligands for sigma opioid receptors in the brain ("sigmaphin"): evidence from binding assays.
Su TP; Weissman AD; Yeh SY
Life Sci; 1986 Jun; 38(24):2199-210. PubMed ID: 3012236
[TBL] [Abstract][Full Text] [Related]
27. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
Clark JA; Liu L; Price M; Hersh B; Edelson M; Pasternak GW
J Pharmacol Exp Ther; 1989 Nov; 251(2):461-8. PubMed ID: 2553920
[TBL] [Abstract][Full Text] [Related]
28. [3H]ethylketocyclazocine binding to NCB-20 hybrid neurotumor cells.
West RE; McLawhon RW; Dawson G; Miller RJ
Mol Pharmacol; 1983 Mar; 23(2):486-92. PubMed ID: 6339880
[TBL] [Abstract][Full Text] [Related]
29. Properties of a selective kappa agonist, U-50,488H.
Lahti RA; VonVoigtlander PF; Barsuhn C
Life Sci; 1982 Nov 15-22; 31(20-21):2257-60. PubMed ID: 6131357
[TBL] [Abstract][Full Text] [Related]
30. Characterization of opioid binding sites in murine neuroblastoma.
Zagon IS; Goodman SR; McLaughlin PJ
Brain Res; 1988 May; 449(1-2):80-8. PubMed ID: 2899449
[TBL] [Abstract][Full Text] [Related]
31. Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes.
Richardson A; Demoliou-Mason C; Barnard EA
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10198-202. PubMed ID: 1332034
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
[TBL] [Abstract][Full Text] [Related]
33. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
Su TP
J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
[TBL] [Abstract][Full Text] [Related]
34. Kappa opiate receptors localized by autoradiography to deep layers of cerebral cortex: relation to sedative effects.
Goodman RR; Snyder SH
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5703-7. PubMed ID: 6127675
[TBL] [Abstract][Full Text] [Related]
35. In vivo receptor binding of opioid drugs at the mu site.
Rosenbaum JS; Holford NH; Sadée W
J Pharmacol Exp Ther; 1985 Jun; 233(3):735-40. PubMed ID: 2989495
[TBL] [Abstract][Full Text] [Related]
36. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line.
McLawhon RW; West RE; Miller RJ; Dawson G
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4309-13. PubMed ID: 6117074
[TBL] [Abstract][Full Text] [Related]
37. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
Tam SW
Eur J Pharmacol; 1985 Feb; 109(1):33-41. PubMed ID: 2986989
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody capable of modulating opioid binding to rat neural membranes.
Bidlack JM; Denton RR
J Biol Chem; 1985 Dec; 260(29):15655-61. PubMed ID: 2999128
[TBL] [Abstract][Full Text] [Related]
39. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
Chavkin C; James IF; Goldstein A
Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
[TBL] [Abstract][Full Text] [Related]
40. Separation of kappa-opioid receptor subtype from frog brain.
Simon J; Benyhe S; Borsodi A; Szücs M; Wollemann M
FEBS Lett; 1985 Apr; 183(2):395-7. PubMed ID: 2985433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
